Metabolic (cytoprotective) therapy of menopausal disturbances
The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevan...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1835 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689396954005504 |
|---|---|
| author | S. N. Tolstov V. B. Mychka |
| author_facet | S. N. Tolstov V. B. Mychka |
| author_sort | S. N. Tolstov |
| collection | DOAJ |
| description | The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevant features of arterial hypertension and endothelial dysfunction development are discussed. The data on Mildronate® clinical use for cardiovascular prevention are summarized. The wide prevalence and multiple clinical manifestations of menopausal disturbances point to the need for their complex therapy. Mildronate® therapy is a new approach for systemic correction of metabolic disturbances in women with climacteric symptoms and menopausal MS. |
| format | Article |
| id | doaj-art-eccc6e6a5d2a4ebb95b2034826ba7444 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2011-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-eccc6e6a5d2a4ebb95b2034826ba74442025-08-20T03:21:39Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-06-01103727510.15829/1728-8800-2011-3-72-751550Metabolic (cytoprotective) therapy of menopausal disturbancesS. N. Tolstov0V. B. Mychka1Saratov State Medical InstituteA.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical ComplexThe paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevant features of arterial hypertension and endothelial dysfunction development are discussed. The data on Mildronate® clinical use for cardiovascular prevention are summarized. The wide prevalence and multiple clinical manifestations of menopausal disturbances point to the need for their complex therapy. Mildronate® therapy is a new approach for systemic correction of metabolic disturbances in women with climacteric symptoms and menopausal MS.https://cardiovascular.elpub.ru/jour/article/view/1835menopausemenopausal metabolic syndromearterial hypertensionmetabolic therapymildronate |
| spellingShingle | S. N. Tolstov V. B. Mychka Metabolic (cytoprotective) therapy of menopausal disturbances Кардиоваскулярная терапия и профилактика menopause menopausal metabolic syndrome arterial hypertension metabolic therapy mildronate |
| title | Metabolic (cytoprotective) therapy of menopausal disturbances |
| title_full | Metabolic (cytoprotective) therapy of menopausal disturbances |
| title_fullStr | Metabolic (cytoprotective) therapy of menopausal disturbances |
| title_full_unstemmed | Metabolic (cytoprotective) therapy of menopausal disturbances |
| title_short | Metabolic (cytoprotective) therapy of menopausal disturbances |
| title_sort | metabolic cytoprotective therapy of menopausal disturbances |
| topic | menopause menopausal metabolic syndrome arterial hypertension metabolic therapy mildronate |
| url | https://cardiovascular.elpub.ru/jour/article/view/1835 |
| work_keys_str_mv | AT sntolstov metaboliccytoprotectivetherapyofmenopausaldisturbances AT vbmychka metaboliccytoprotectivetherapyofmenopausaldisturbances |